ARVN
Price
$7.55
Change
-$0.25 (-3.21%)
Updated
Jun 27 closing price
Capitalization
551.45M
33 days until earnings call
AXON
Price
$818.60
Change
+$14.65 (+1.82%)
Updated
Jun 27 closing price
Capitalization
63.73B
45 days until earnings call
Interact to see
Advertisement

ARVN vs AXON

Header iconARVN vs AXON Comparison
Open Charts ARVN vs AXONBanner chart's image
Arvinas
Price$7.55
Change-$0.25 (-3.21%)
Volume$2.93M
Capitalization551.45M
Axon Enterprise
Price$818.60
Change+$14.65 (+1.82%)
Volume$1.01M
Capitalization63.73B
ARVN vs AXON Comparison Chart in %
Loading...
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARVN vs. AXON commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a StrongBuy and AXON is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (ARVN: $7.55 vs. AXON: $818.60)
Brand notoriety: ARVN and AXON are both not notable
ARVN represents the Biotechnology, while AXON is part of the Aerospace & Defense industry
Current volume relative to the 65-day Moving Average: ARVN: 88% vs. AXON: 175%
Market capitalization -- ARVN: $551.45M vs. AXON: $63.73B
ARVN [@Biotechnology] is valued at $551.45M. AXON’s [@Aerospace & Defense] market capitalization is $63.73B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $271.41B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B. The average market capitalization across the [@Aerospace & Defense] industry is $20.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 1 FA rating(s) are green whileAXON’s FA Score has 3 green FA rating(s).

  • ARVN’s FA Score: 1 green, 4 red.
  • AXON’s FA Score: 3 green, 2 red.
According to our system of comparison, AXON is a better buy in the long-term than ARVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 5 TA indicator(s) are bullish while AXON’s TA Score has 3 bullish TA indicator(s).

  • ARVN’s TA Score: 5 bullish, 4 bearish.
  • AXON’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ARVN is a better buy in the short-term than AXON.

Price Growth

ARVN (@Biotechnology) experienced а +1.55% price change this week, while AXON (@Aerospace & Defense) price change was +5.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was +2.26%. For the same industry, the average monthly price growth was +10.02%, and the average quarterly price growth was +35.88%.

Reported Earning Dates

ARVN is expected to report earnings on Jul 31, 2025.

AXON is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Aerospace & Defense (+2.26% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($63.7B) has a higher market cap than ARVN($551M). AXON YTD gains are higher at: 37.737 vs. ARVN (-60.589). AXON has higher annual earnings (EBITDA): 398M vs. ARVN (-89.3M). AXON has more cash in the bank: 2.37B vs. ARVN (954M). ARVN has less debt than AXON: ARVN (10.5M) vs AXON (2.05B). AXON has higher revenues than ARVN: AXON (2.23B) vs ARVN (427M).
ARVNAXONARVN / AXON
Capitalization551M63.7B1%
EBITDA-89.3M398M-22%
Gain YTD-60.58937.737-161%
P/E RatioN/A197.25-
Revenue427M2.23B19%
Total Cash954M2.37B40%
Total Debt10.5M2.05B1%
FUNDAMENTALS RATINGS
ARVN vs AXON: Fundamental Ratings
ARVN
AXON
OUTLOOK RATING
1..100
6385
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
99
Overvalued
PROFIT vs RISK RATING
1..100
1006
SMR RATING
1..100
8654
PRICE GROWTH RATING
1..100
642
P/E GROWTH RATING
1..100
1007
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARVN's Valuation (17) in the Biotechnology industry is significantly better than the same rating for AXON (99). This means that ARVN’s stock grew significantly faster than AXON’s over the last 12 months.

AXON's Profit vs Risk Rating (6) in the Biotechnology industry is significantly better than the same rating for ARVN (100). This means that AXON’s stock grew significantly faster than ARVN’s over the last 12 months.

AXON's SMR Rating (54) in the Biotechnology industry is in the same range as ARVN (86). This means that AXON’s stock grew similarly to ARVN’s over the last 12 months.

AXON's Price Growth Rating (2) in the Biotechnology industry is somewhat better than the same rating for ARVN (64). This means that AXON’s stock grew somewhat faster than ARVN’s over the last 12 months.

AXON's P/E Growth Rating (7) in the Biotechnology industry is significantly better than the same rating for ARVN (100). This means that AXON’s stock grew significantly faster than ARVN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARVNAXON
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
53%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
74%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 6 days ago
79%
Bearish Trend 1 day ago
68%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
82%
Bearish Trend 11 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
61%
Aroon
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGALX16.65N/A
N/A
Baillie Gifford Global Alpha Equities 4
WBALX16.88N/A
N/A
Weitz Conservative Allocation-Inv Cl
ECCGX15.15N/A
N/A
Eaton Vance China Equity C
PASVX51.47N/A
N/A
T. Rowe Price Small-Cap Value Adv
MNSQX22.36N/A
N/A
Invesco Main Street Small Cap R5

ARVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARVN has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ARVN jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARVN
1D Price
Change %
ARVN100%
-3.14%
AXON - ARVN
46%
Loosely correlated
+1.82%
VCYT - ARVN
46%
Loosely correlated
+2.13%
ERAS - ARVN
40%
Loosely correlated
+1.98%
ATXS - ARVN
40%
Loosely correlated
+2.94%
SRPT - ARVN
40%
Loosely correlated
-0.81%
More